Non-invasive monitoring of Streptococcus pyogenes vaccine efficacy using biophotonic imaging

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Alam, Faraz M ^a   Bateman, Colin ^a   Turner, Claire E ^a   Wiles, Siouxsie ^a,b   Sriskandan, Shiranee ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BASE SEQUENCE; DNA PRIMERS; FEMALE; LUMINESCENCE; MICE; NASOPHARYNX; PHOTONS; STREPTOCOCCUS PYOGENES;

EID: 84894269970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082123     Document Type: Article

References (30)

1. Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5: 685-694. doi:10.1016/S1473-3099(05)70267-X. PubMed: 16253886. (Pubitemid 41505357)
2. Steer AC, Batzloff MR, Mulholland K, Carapetis JR (2009) Group A streptococcal vaccines: facts versus fantasy. Curr Opin Infect Dis 22: 544-552. doi:10.1097/QCO.0b013e328332bbfe. PubMed: 19797947.
3. Dale JB, Penfound Ta, Chiang EY, Walton WJ (2011) New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine 29: 8175-8178. doi:10.1016/j.vaccine. 2011.09.005. PubMed: 21920403.
4. Sheel M, Pandey M, Good MF, Batzloff MR (2010) Correlation between bioluminescence and bacterial burden in passively protected mice challenged with a recombinant bioluminescent M49 group A streptococcus Strain. Clin Vaccine Immunol 17: 127-133. doi:10.1128/CVI.00256-09. PubMed: 19889937.
5. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9: 611-616. doi:10.1016/S1473- 3099(09)70178-1. PubMed: 19778763.
6. Park HS, Cleary PP (2005) Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils. Infect Immun 73: 7878-7886. doi:10.1128/IAI.73.12.7878-7886.2005. PubMed: 16299278.
7. Schulze K, Medina E, Chhatwal GS, Guzmán CA (2003) Stimulation of long-lasting protection against Streptococcus pyogenes after intranasal vaccination with non adjuvanted fibronectin-binding domain of the SfbI protein. Vaccine 21: 1958-1964. doi:10.1016/S0264-410X(02)00803-4. PubMed: 12706684.
8. Kawabata S, Kunitomo E, Terao Y, Nakagawa I, Kikuchi K et al. (2001) Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice. Infect Immun 69: 924-930. doi:10.1128/IAI.69.2.924-930.2001. PubMed: 11159987. (Pubitemid 32109558)
9. Rodríguez-Ortega M, Norais N, Bensi G, Liberatori S, Capo S et al. (2006) Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol 24: 191-197. doi:10.1038/nbt1179. PubMed: 16415855. (Pubitemid 43221703)
10. Bensi G, Mora M, Tuscano G, Biagini M, Chiarot E et al. (2012) Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case. Mol Cell Proteomics 11: M111: 015693.
11. Kurupati P, Turner CE, Tziona I, Lawrenson RA, Alam FM et al. (2010) Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract. Mol Microbiol 76: 1387-1397. doi:10.1111/j.1365-2958.2010.07065.x. PubMed: 20158613.
12. Turner CE, Kurupati P, Wiles S, Edwards RJ, Sriskandan S (2009) Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi. Vaccine 27: 4923-4929. doi:10.1016/j.vaccine.2009.06.042. PubMed: 19563892.
13. Fritzer A, Senn BM, Minh DB, Hanner M, Gelbmann D et al. (2010) Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine. Infect Immun 78: 4051-4067. doi:10.1128/IAI.00295-10. PubMed: 20624906.
14. Andreu N, Zelmer A, Wiles S (2011) Noninvasive biophotonic imaging for studies of infectious disease. FEMS Microbiol Rev 35: 360-394. doi:10.1111/j.1574-6976.2010.00252.x. PubMed: 20955395.
15. Russell WMS, Burch RL (1959) The Principles of Humane Experimental Technique. Methuen.
16. Park HS, Francis KP, Yu J, Cleary PP (2003) Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol 171: 2532-2537. PubMed: 12928403. (Pubitemid 37025563)
17. Alam FM, Turner CE, Smith K, Wiles S, Sriskandan S (2013) Inactivation of the CovR/S virulence regulator impairs infection in an improved murine model of Streptococcus pyogenes naso-pharyngeal infection. PLOS ONE 8: e61655. doi:10.1371/journal.pone.0061655. PubMed: 23637876.
18. Manetti AGO, Zingaretti C, Falugi F, Capo S, Bombaci M et al. (2007) Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol Microbiol 64: 968-983. doi:10.1111/j.1365-2958.2007.05704.x. PubMed: 17501921. (Pubitemid 46743959)
19. Beard SJ, Salisbury VC, Lewis RJ, Sharpe JA, MacGowan AP (2002) Expression of lux genes in a clinical isolate of Streptococcus pneumoniae: using bioluminescence to monitor gemifloxacin activity. Antimicrob Agents Chemother 46: 538-542. doi:10.1128/AAC.46.2.538-542.2002. PubMed: 11796373. (Pubitemid 34087211)
20. Yanisch-Perron C, Vieira J, Messing J (1985) Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33: 103-119. doi:10.1016/0378-1119(85)90120-9. PubMed: 2985470. (Pubitemid 15122816)
21. Riedel CU, Monk IR, Casey PG, Morrissey D, O'Sullivan GC et al. (2007) An improved luciferase tagging system for Listeria monocytogenes allows real-time monitoring in vivo and in vitro. Appl Environ Microbiol 73: 3091-3094. doi:10.1128/AEM.02940-06. PubMed: 17351089. (Pubitemid 46718595)
22. Sriskandan S, Unnikrishnan M, Krausz T, Cohen J (1999) Molecular analysis of the role of streptococcal pyrogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes. Mol Microbiol 33: 778-790. doi:10.1046/j.1365-2958.1999.01525.x. PubMed: 10447887. (Pubitemid 29392658)
23. Biswas I, Jha JK, Fromm N (2008) Shuttle expression plasmids for genetic studies in Streptococcus mutans. Microbiology 154: 2275-2282. doi:10.1099/mic.0.2008/019265-0. PubMed: 18667560.
24. Turner CE, Kurupati P, Jones MD, Edwards RJ, Sriskandan S (2009) Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection. J Infect Dis 200: 555-563. doi:10.1086/603541. PubMed: 19591574.
25. La Rosa SL, Diep DB, Nes IF, Brede DA (2012) Construction and application of a luxABCDE reporter system for real-time monitoring of Enterococcus faecalis gene expression and growth. Appl Environ Microbiol 78: 7003-7011. doi:10.1128/AEM.02018-12. PubMed: 22843522.
26. Van der Meer JR, Tropel D, Jaspers M (2004) Illuminating the detection chain of bacterial bioreporters. Environ Microbiol 6: 1005-1020. doi:10.1111/j.1462-2920.2004.00655.x. PubMed: 15344926. (Pubitemid 39275255)
27. Bose JL, Rosenberg CS, Stabb EV (2008) Effects of luxCDABEG induction in Vibrio fischeri: enhancement of symbiotic colonization and conditional attenuation of growth in culture. Arch Microbiol 190: 169-183. doi:10.1007/s00203-008-0387-1. PubMed: 18521572.
28. Troy T, Jekic-McMullen D, Sambucetti L, Rice BW (2004) Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol Imaging 3: 9-23. doi:10.1162/153535004773861688. PubMed: 15142408.
29. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM (2006) Genome-Wide Analysis of Group A Streptococci Reveals a Mutation That Modulates Global Phenotype and Disease Specificity. PLoS Pathog 2: 0041-0049
30. Beyer-Sehlmeyer G, Kreikemeyer B, Hörster A, Podbielski A (2005) Analysis of the growth phase-associated transcriptome of Streptococcus pyogenes. Int J Med Microbiol 295: 161-177. doi:10.1016/j.ijmm.2005.02.010. PubMed: 16044856. (Pubitemid 40776101)